Michael P. Dube, VP, Chief Accounting Officer at Intellia Therapeutics, Inc. (NTLA), sold 2,641 shares at $16.78 ($44K) on 2026-07-01, disclosed to the SEC on 2026-07-06.
Open-market sale of $44k NTLA by VP, Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NTLA | SELL | 2025-10-03 | $33K | — | Filing → |
| NTLA | SELL | 2025-07-03 | $25K | — | Filing → |
| NTLA | SELL | 2025-01-07 | $17K | — | Filing → |